Ability Pharma Overview

  • Founded

  • 2009

Founded
  • Status

  • Private

  • Employees

  • 22

Employees
  • Latest Deal Type

  • Accelerator/​Inc

  • Latest Deal Amount

  • $2.85M

  • Investors

  • 12

Ability Pharma General Information

Description

Developer of medical therapies intended to focus on developing fully differentiated oral targeted anticancer compounds. The company's targeted therapies are drugs that kill cancer cells through the induction of robust cytotoxic autophagy, enabling doctors to improve the lives of the patients and cure them.

Contact Information

Website
www.abilitypharma.com
Formerly Known As
AB-Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Avinguda Parc Tecnològic, 3 Centre d'Empreses de Noves Tecnologies
  • Parc Tecnològic del Vallès, Cerdanyola
  • 08290 Barcelona
  • Spain
+34 935 00 00 00

Ability Pharma Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ability Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Accelerator/Incubator 01-Dec-2021 $2.85M 000.00 Completed Generating Revenue
13. Later Stage VC 16-Jul-2021 00.000 0000 000.00 Completed Generating Revenue
12. Corporate 22-Oct-2020 000 000.00 Completed Clinical Trials - Phase 2
11. Equity Crowdfunding 17-Nov-2020 00.000 000.00 Completed Clinical Trials - Phase 2
10. Grant 22-Oct-2020 00.000 000.00 Completed Clinical Trials - Phase 2
9. Later Stage VC 21-Apr-2020 00.000 000.00 00.000 Completed Clinical Trials - Phase 2
8. Accelerator/Incubator 18-Mar-2020 00.000 000.00 Completed Clinical Trials - Phase 2
7. Later Stage VC 12-Sep-2019 00.000 000.00 Completed Clinical Trials - Phase 2
6. Equity Crowdfunding 11-Dec-2018 $1.4M $11.3M Completed Clinical Trials - Phase 1
5. Early Stage VC 11-Sep-2013 $6.64M $9.9M Completed Clinical Trials - Phase 1
To view Ability Pharma’s complete valuation and funding history, request access »

Ability Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 213,768 $1.187813 $5.56 $5.56 1x $5.56 12.28%
Ordinary 103,092 $1.187813 $13.83 $13.83 1x $13.83 5.92%
To view Ability Pharma’s complete cap table history, request access »

Ability Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical therapies intended to focus on developing fully differentiated oral targeted anticancer compounds.
Drug Discovery
Barcelona, Spain
22 As of 2022
000.00
000000000000 000.00

000 00

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000 000000000
New York, NY
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ability Pharma Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00000000 Venture Capital-Backed New York, NY 00 00000 00000000000 00000
000000000 000000 Venture Capital-Backed Burlington, MA 00 00000 0000000000 0 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
You’re viewing 5 of 8 competitors. Get the full list »

Ability Pharma Patents

  • 10

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Ability Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3163864-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
EP-4103170-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
US-20230088704-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
AU-2021220258-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
US-20210154166-A1 A pharmaceutical combination for the treatment of cancer Active 16-May-2017 A61K31/201
To view Ability Pharma’s complete patent history, request access »

Ability Pharma Executive Team (13)

Name Title Board Seat Contact Info
Jordi Espadaler Ph.D Co-Founder & Scientific Advisor
Carles Domènech Ph.D Co-Founder, Vice President of Business Development and Licensing, Chief Executive Officer, Board Member, Executive Chairman & Chief Scientific Officer
Marc Cortal MD Director, Clinical Research
José Manuel Valadés Board Member & General Secretary
Gemma Fierro Vice President, Clinical & Regulatory Affairs
You’re viewing 5 of 13 executive team members. Get the full list »

Ability Pharma Board Members (9)

Name Representing Role Since
Carles Domènech Ph.D Ability Pharma Co-Founder, Vice President of Business Development and Licensing, Chief Executive Officer, Board Member, Executive Chairman & Chief Scientific Officer 000 0000
Germán Cutillas Fitalent Board Member 000 0000
José Manuel Valadés Ability Pharma Board Member & General Secretary 000 0000
Luis Sánchez-Lafuente Self Chairman 000 0000
Miquel Bonachera Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Ability Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ability Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
U.S. Food and Drug Administration Government 000 0000 000000 0
Centro para el Desarrollo Tecnológico Industrial Government Minority 000 0000 000000 0
Fundacion Cajanavarra Limited Partner Minority 000 0000 000000 0
European Investment Bank Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial